AB Science (AB Science) FCF Margin % : -2,120.62% (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is AB Science FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AB Science's Free Cash Flow for the six months ended in Jun. 2023 was $-10.29 Mil. AB Science's Revenue for the six months ended in Jun. 2023 was $0.49 Mil. Therefore, AB Science's FCF Margin % for the quarter that ended in Jun. 2023 was -2,120.62%.

As of today, AB Science's current FCF Yield % is -9.90%.

The historical rank and industry rank for AB Science's FCF Margin % or its related term are showing as below:

ABSCF' s FCF Margin % Range Over the Past 10 Years
Min: -2257.56 Med: -1072.45 Max: -686.39
Current: -1232.73

During the past 13 years, the highest FCF Margin % of AB Science was -686.39%. The lowest was -2257.56%. And the median was -1072.45%.

ABSCF's FCF Margin % is ranked worse than
96.49% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs ABSCF: -1232.73

AB Science FCF Margin % Historical Data

The historical data trend for AB Science's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science FCF Margin % Chart

AB Science Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-1,603.67

-989.29

-876.79

-1,103.91

-1,890.54

AB Science Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															-1,062.58	-1,145.85	-2,880.30	1.15	-2,120.62

Competitive Comparison of AB Science's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, AB Science's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AB Science's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AB Science's FCF Margin % distribution charts can be found below:

* The bar in red indicates where AB Science's FCF Margin % falls into.

AB Science FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

AB Science's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-19.189	/	1.015
	=	-1,890.54 %

AB Science's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-10.285	/	0.485
	=	-2,120.62 %

AB Science FCF Margin % Related Terms

Thank you for viewing the detailed overview of AB Science's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

AB Science (AB Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (OTCPK:ABSCF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AB:France

Address

3, Avenue George V, Paris, FRA, 75008

Website

https://www.ab-science.com

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.